This investigation examined the neuroprotective capabilities of HSP, both in isolation and in conjunction with minocycline (a known microglial inhibitor), within a rat model of Huntington’s disease (HD) induced by quinolinic acid (QA). The gene discussed is HSP90B2P; the disease is juvenile Huntington disease.